Eat Right, Screen Right — nutrition and screening guidance to lower colorectal cancer risk

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Eat Right, Screen Right Extension delivers six tailored, web-based lessons that present colorectal cancer screening guidelines and personalized nutrition risk feedback (for red and processed meat, alcohol, and other factors). Participants follow a branched conversational pathway to select optional prevention topics and may access five additional in-depth modules. Outcomes are self-reported and include changes in cancer information overload, dietary intentions, and screening intentions. The program is an online extension of previously funded pilot work and is delivered through the University of Florida platform.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 18 years or older
* Able to understand English
* Access to a computer or mobile device

Exclusion Criteria:

* 17 years or younger
* Unable to understand English
* No access to a computer or mobile device

Where it's running

• University Florida - Online Study
  Gainesville, Florida, United States Recruiting

Study contacts

• Study coordinator: Melissa Vilaro, PhD, MPH
• Email: mgraveley@ufl.edu
• Phone: 352-273-3525

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• ULTRA-SAFE: Personalize colorectal cancer surveillance using annual FIT with optional earlier colonoscopy

  This trial tests whether annual fecal immunochemical testing (FIT) with earlier colonoscopy on positive results is better than a fixed colonoscopy at three years for people at very high risk after removing multiple advanced adenomas.

  Recruiting at 4 sites National Taiwan University Hospital · Taipei, Taipei and 3 other locations · NCT07378930

• Diet changes to see if bile acids and gut bugs shift in people with colorectal adenoma

  A diet shift toward more plants and fewer animal products is being tested to see if it changes gut bile acids and microbiome in adults with a history of colorectal adenoma.

  Recruiting Massachusetts General Hospital · Boston, Massachusetts · NCT07162337

• Preventing early-onset colorectal tumors with tirzepatide

  This trial will test whether the diabetes/weight-loss drug tirzepatide changes tissue, blood, urine, stool, and microbiome markers linked to colorectal cancer risk in adults under 50 who recently had adenomas.

  Recruiting Phase 1 Massachusetts General Hospital · Boston, Massachusetts · NCT07095517

• Lifestyle advice for people with adenomas after a positive colorectal screening test

  This trial will try giving evidence-based diet and lifestyle advice to people in France who had a positive FIT and adenomas but no cancer to see if it improves their diet, activity, quality of life, and body measurements over one year.

  Recruiting Centre Leon Berard · Lyon, France · NCT06827366

• Carrot juice for preventing colorectal cancer in high-risk patients

  This study is testing if drinking carrot juice every day can help prevent colorectal cancer from coming back in patients who are at high risk after surgery.

  Recruiting Odense University Hospital · Odense · NCT06335420

• Predicting Colorectal Adenoma Recurrence and Cancer Risk Using Integrated TCM and Western Data

  This study tests a risk-prediction model that combines Traditional Chinese Medicine and Western medical features to see if it can forecast recurrence and malignant change in colorectal adenomas.

  Recruiting Beijing Friendship Hospital · Beijing, Beijing Municipality · NCT07611266

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.